NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00644306,Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma,https://clinicaltrials.gov/study/NCT00644306,IFM 01/01,TERMINATED,"In multiple myeloma, combination chemotherapy with melphalan plus prednisone has been usedsince the 1960s and is regarded as the standard of care in very elderly patients. We assess whether the addition of thalidomide at 100 mg/day to this combination would improve survival.",NO,"Newly Diagnosed, Multiple Myeloma","DRUG: Thalidomide|DRUG: melphalan, prednisone|DRUG: melphalan, prednisone, thalidomide","overall Survival, May 2007","Progression Free Survival, May 2007|Response rates, May 2007|Safety, May 2007",,"Central Hospital, Nancy, France",,ALL,OLDER_ADULT,PHASE3,232,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT,"University Hospital, Nancy",2002-04,,2007-05,2008-03-26,,2008-03-26,"CHU Nancy - Brabois, rue du morvan, Vandoeuvre, 54511, France",
